Bank of Montreal’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.4K Buy
+200
New +$38.3K ﹤0.01% 3389
2024
Q4
Sell
-12
Closed -$1.59K 3774
2024
Q3
$1.59K Buy
+12
New +$1.57K ﹤0.01% 3770
2023
Q3
Sell
-19
Closed -$2.58K 4042
2023
Q2
$2.58K Hold
19
﹤0.01% 3882
2023
Q1
$1.85K Hold
19
﹤0.01% 3713
2022
Q4
$2.66K Buy
+19
New +$2.65K ﹤0.01% 3877
2019
Q1
Sell
-38
Closed -$25K 4537
2018
Q4
$25K Buy
+38
New +$39.8K ﹤0.01% 3562
2018
Q2
Sell
-108
Closed -$172K 4800
2018
Q1
$172K Buy
108
+60
+125% +$112K ﹤0.01% 2698
2017
Q4
$74K Buy
+48
New +$73.5K ﹤0.01% 3122

Other funds holding LABU

Bank of Montreal's LABU Position: Q2 2026 in Review

Bank of Montreal opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 200 shares worth $58.4K. The stake represents ﹤0.01% of the portfolio and ranks #3389 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in LABU as recently as Q3 2024.

Bank of Montreal first reported a position in LABU in Q4 2017 and has held it in 8 quarters since. The position peaked at $172K in Q1 2018. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Bank of Montreal held 200 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $58.4K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Bank of Montreal position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3389 holding.
  • Bank of Montreal first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and has held it in 8 quarters since.
  • Bank of Montreal's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $172K in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.